Sectors
Pharma and biotech on a roll as drug approvals hit 18-year high
U.S. drug approvals in 2014 hit their highest level in 18 years and recommendations in Europe also came at a rapid rate, driven by expensive new treatments for cancer and rare diseases.
Aspen, Cipla win share of $860 million South Africa AIDS drug tender
South Africa will spend 10 billion rand ($860 million) between 2015 and 2017 on life-prolonging HIV/AIDS treatment drugs, health authorities said on Wednesday, as studies show the prevalence of the virus is rising.
Low-risk 'worm' removed at hacked South Korea nuclear operator
South Korean authorities have found evidence that a low-risk computer "worm" had been removed from devices connected to some nuclear plant control systems, but no harmful virus was found in reactor controls threatened by a hacker.
Fees, expenses for Detroit bankruptcy hit nearly $178 million
Detroit's historic bankruptcy, which officially ended earlier this month, cost the city nearly $178 million in fees and expenses for teams of lawyers and consultants, according to a city court filing on Tuesday.




